elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q24652988-E5331793-BB3D-4725-921C-D67BC0863BD8
Q24652988-E5331793-BB3D-4725-921C-D67BC0863BD8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24652988-E5331793-BB3D-4725-921C-D67BC0863BD8
Tamoxifen: catalyst for the change to targeted therapy
P2860
Q24652988-E5331793-BB3D-4725-921C-D67BC0863BD8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24652988-E5331793-BB3D-4725-921C-D67BC0863BD8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
13e2b9d5ff2db45fa78d140a4f1300b5a7fa5138
P2860
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation